Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 1 March 2005, Vol. 105, No. 5, pp. 2214-2219.
Prepublished online as a Blood First Edition Paper on October 28, 2004; DOI 10.1182/blood-2004-07-2921.


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2004-07-2921v1
105/5/2214    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Beyth, S.
Right arrow Articles by Rachmilewitz, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Beyth, S.
Right arrow Articles by Rachmilewitz, J.
Related Collections
Right arrow Immunobiology
Right arrow Transplantation
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

TRANSPLANTATION

Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness

Shaul Beyth, Zipora Borovsky, Dror Mevorach, Meir Liebergall, Zulma Gazit, Hadi Aslan, Eithan Galun, and Jacob Rachmilewitz

From the Goldyne Savad Institute of Gene Therapy; Department of Orthopedic Surgery; The Laboratory for Cellular and Molecular Immunology, Rheumatology Unit, Department of Medicine; and the Skeletal Biotechnology Laboratory, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.

Infusion of either embryonic or mesenchymal stem cells prolongs the survival of organ transplants derived from stem cell donors and prevents graft-versus-host-disease (GVHD). An in-depth mechanistic understanding of this tolerization phenomenon could lead to novel cell-based therapies for transplantation. Here we demonstrate that while human mesenchymal stem cells (hMSCs) can promote superantigen-induced activation of purified T cells, addition of antigen-presenting cells (APCs; either monocytes or dendritic cells) to the cultures inhibits the T-cell responses. This contact- and dose-dependent inhibition is accompanied by secretion of large quantities of interleukin (IL)–10 and aberrant APC maturation, which can be partially overridden by the addition of factors that promote APC maturation (ie, lipopolysaccharide [LPS] or anti-CD40 monoclonal antibody [mAb]). Thus, our data support an immunoregulatory mechanism wherein hMSCs inhibit T cells indirectly by contact-dependent induction of regulatory APCs with T-cell–suppressive properties. Our data may reveal a physiologic phenomenon whereby the development of a distinct APC population is regulated by the tissue's cellular microenvironment.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Circ. Res.Home page
J. S. Burchfield, M. Iwasaki, M. Koyanagi, C. Urbich, N. Rosenthal, A. M. Zeiher, and S. Dimmeler
Interleukin-10 From Transplanted Bone Marrow Mononuclear Cells Contributes to Cardiac Protection After Myocardial Infarction
Circ. Res., July 18, 2008; 103(2): 203 - 211.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
D. J. Weiss, J. K. Kolls, L. A. Ortiz, A. Panoskaltsis-Mortari, and D. J. Prockop
Stem Cells and Cell Therapies in Lung Biology and Lung Diseases
Proceedings of the ATS, July 15, 2008; 5(5): 637 - 667.
[Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
R. Atoui, D. Shum-Tim, and R. C.J. Chiu
Myocardial regenerative therapy: immunologic basis for the potential "universal donor cells".
Ann. Thorac. Surg., July 1, 2008; 86(1): 327 - 334.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
I. Kassis, N. Grigoriadis, B. Gowda-Kurkalli, R. Mizrachi-Kol, T. Ben-Hur, S. Slavin, O. Abramsky, and D. Karussis
Neuroprotection and Immunomodulation With Mesenchymal Stem Cells in Chronic Experimental Autoimmune Encephalomyelitis
Arch Neurol, June 1, 2008; 65(6): 753 - 761.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
F. Morandi, L. Raffaghello, G. Bianchi, F. Meloni, A. Salis, E. Millo, S. Ferrone, V. Barnaba, and V. Pistoia
Immunogenicity of Human Mesenchymal Stem Cells in HLA-Class I-Restricted T-Cell Responses Against Viral or Tumor-Associated Antigens
Stem Cells, May 1, 2008; 26(5): 1275 - 1287.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
P. Comoli, F. Ginevri, R. Maccario, M. A. Avanzini, M. Marconi, A. Groff, A. Cometa, M. Cioni, L. Porretti, W. Barberi, et al.
Human mesenchymal stem cells inhibit antibody production induced in vitro by allostimulation
Nephrol. Dial. Transplant., April 1, 2008; 23(4): 1196 - 1202.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
M. A. Kriegel, S. Adam-Klages, C. Gabler, N. Blank, M. Schiller, C. Scheidig, J. R. Kalden, and H.-M. Lorenz
Anti-HLA-DR-triggered monocytes mediate in vitro T cell anergy
Int. Immunol., April 1, 2008; 20(4): 601 - 613.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
J. Y. Oh, M. K. Kim, M. S. Shin, H. J. Lee, J. H. Ko, W. R. Wee, and J. H. Lee
The Anti-Inflammatory and Anti-Angiogenic Role of Mesenchymal Stem Cells in Corneal Wound Healing Following Chemical Injury
Stem Cells, April 1, 2008; 26(4): 1047 - 1055.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y.-P. Li, S. Paczesny, E. Lauret, S. Poirault, P. Bordigoni, F. Mekhloufi, O. Hequet, Y. Bertrand, J.-P. Ou-Yang, J.-F. Stoltz, et al.
Human Mesenchymal Stem Cells License Adult CD34+ Hemopoietic Progenitor Cells to Differentiate into Regulatory Dendritic Cells through Activation of the Notch Pathway
J. Immunol., February 1, 2008; 180(3): 1598 - 1608.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
G. M. Spaggiari, A. Capobianco, H. Abdelrazik, F. Becchetti, M. C. Mingari, and L. Moretta
Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2
Blood, February 1, 2008; 111(3): 1327 - 1333.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
M. Magatti, S. De Munari, E. Vertua, L. Gibelli, G. S. Wengler, and O. Parolini
Human Amnion Mesenchyme Harbors Cells with Allogeneic T-Cell Suppression and Stimulation Capabilities
Stem Cells, January 1, 2008; 26(1): 182 - 192.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
F. Liotta, R. Angeli, L. Cosmi, L. Fili, C. Manuelli, F. Frosali, B. Mazzinghi, L. Maggi, A. Pasini, V. Lisi, et al.
Toll-Like Receptors 3 and 4 Are Expressed by Human Bone Marrow-Derived Mesenchymal Stem Cells and Can Inhibit Their T-Cell Modulatory Activity by Impairing Notch Signaling
Stem Cells, January 1, 2008; 26(1): 279 - 289.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. J. Nauta and W. E. Fibbe
Immunomodulatory properties of mesenchymal stromal cells
Blood, November 15, 2007; 110(10): 3499 - 3506.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
D. Chabannes, M. Hill, E. Merieau, J. Rossignol, R. Brion, J. P. Soulillou, I. Anegon, and M. C. Cuturi
A role for heme oxygenase-1 in the immunosuppressive effect of adult rat and human mesenchymal stem cells
Blood, November 15, 2007; 110(10): 3691 - 3694.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
G. Chamberlain, J. Fox, B. Ashton, and J. Middleton
Concise Review: Mesenchymal Stem Cells: Their Phenotype, Differentiation Capacity, Immunological Features, and Potential for Homing
Stem Cells, November 1, 2007; 25(11): 2739 - 2749.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
I. Rasmusson, M. Uhlin, K. Le Blanc, and V. Levitsky
Mesenchymal stem cells fail to trigger effector functions of cytotoxic T lymphocytes
J. Leukoc. Biol., October 1, 2007; 82(4): 887 - 893.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Jones, N. Horwood, A. Cope, and F. Dazzi
The Antiproliferative Effect of Mesenchymal Stem Cells Is a Fundamental Property Shared by All Stromal Cells
J. Immunol., September 1, 2007; 179(5): 2824 - 2831.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. A. Haniffa, X.-N. Wang, U. Holtick, M. Rae, J. D. Isaacs, A. M. Dickinson, C. M. U. Hilkens, and M. P. Collin
Adult Human Fibroblasts Are Potent Immunoregulatory Cells and Functionally Equivalent to Mesenchymal Stem Cells
J. Immunol., August 1, 2007; 179(3): 1595 - 1604.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. Gupta, X. Su, B. Popov, J. W. Lee, V. Serikov, and M. A. Matthay
Intrapulmonary Delivery of Bone Marrow-Derived Mesenchymal Stem Cells Improves Survival and Attenuates Endotoxin-Induced Acute Lung Injury in Mice
J. Immunol., August 1, 2007; 179(3): 1855 - 1863.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
N. Nishiyama, S. Miyoshi, N. Hida, T. Uyama, K. Okamoto, Y. Ikegami, K. Miyado, K. Segawa, M. Terai, M. Sakamoto, et al.
The Significant Cardiomyogenic Potential of Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells In Vitro
Stem Cells, August 1, 2007; 25(8): 2017 - 2024.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
F. Djouad, L.-M. Charbonnier, C. Bouffi, P. Louis-Plence, C. Bony, F. Apparailly, C. Cantos, C. Jorgensen, and D. Noel
Mesenchymal Stem Cells Inhibit the Differentiation of Dendritic Cells Through an Interleukin-6-Dependent Mechanism
Stem Cells, August 1, 2007; 25(8): 2025 - 2032.
[Abstract] [Full Text] [PDF]


Home page
haematolHome page
F. Locatelli, R. Maccario, and F. Frassoni
Mesenchymal stromal cells, from indifferent spectators to principal actors. Are we going to witness a revolution in the scenario of allograft and immune-mediated disorders?
Haematologica, July 1, 2007; 92(7): 872 - 877.
[Full Text] [PDF]


Home page
haematolHome page
C. Prevosto, M. Zancolli, P. Canevali, M. R. Zocchi, and A. Poggi
Generation of CD4+ or CD8+ regulatory T cells upon mesenchymal stem cell-lymphocyte interaction
Haematologica, July 1, 2007; 92(7): 881 - 888.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
J. Xu, C. R. Woods, A. L. Mora, R. Joodi, K. L. Brigham, S. Iyer, and M. Rojas
Prevention of endotoxin-induced systemic response by bone marrow-derived mesenchymal stem cells in mice
Am J Physiol Lung Cell Mol Physiol, July 1, 2007; 293(1): L131 - L141.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
G. Kasper, N. Dankert, J. Tuischer, M. Hoeft, T. Gaber, J. D. Glaeser, D. Zander, M. Tschirschmann, M. Thompson, G. Matziolis, et al.
Mesenchymal Stem Cells Regulate Angiogenesis According to Their Mechanical Environment
Stem Cells, April 1, 2007; 25(4): 903 - 910.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
K. Sato, K. Ozaki, I. Oh, A. Meguro, K. Hatanaka, T. Nagai, K. Muroi, and K. Ozawa
Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells
Blood, January 1, 2007; 109(1): 228 - 234.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
C.-J. Chang, M.-L. Yen, Y.-C. Chen, C.-C. Chien, H.-I. Huang, C.-H. Bai, and B. L. Yen
Placenta-Derived Multipotent Cells Exhibit Immunosuppressive Properties That Are Enhanced in the Presence of Interferon-{gamma}
Stem Cells, November 1, 2006; 24(11): 2466 - 2477.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
R. Yanez, M. L. Lamana, J. Garcia-Castro, I. Colmenero, M. Ramirez, and J. A. Bueren
Adipose Tissue-Derived Mesenchymal Stem Cells Have In Vivo Immunosuppressive Properties Applicable for the Control of the Graft-Versus-Host Disease
Stem Cells, November 1, 2006; 24(11): 2582 - 2591.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
M. Tomita, T. Mori, K. Maruyama, T. Zahir, M. Ward, A. Umezawa, and M. J. Young
A Comparison of Neural Differentiation and Retinal Transplantation with Bone Marrow-Derived Cells and Retinal Progenitor Cells
Stem Cells, October 1, 2006; 24(10): 2270 - 2278.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. J. Nauta, A. B. Kruisselbrink, E. Lurvink, R. Willemze, and W. E. Fibbe
Mesenchymal Stem Cells Inhibit Generation and Function of Both CD34+-Derived and Monocyte-Derived Dendritic Cells
J. Immunol., August 15, 2006; 177(4): 2080 - 2087.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. L. Chan, K. C. Tang, A. P. Patel, L. M. Bonilla, N. Pierobon, N. M. Ponzio, and P. Rameshwar
Antigen-presenting property of mesenchymal stem cells occurs during a narrow window at low levels of interferon-{gamma}
Blood, June 15, 2006; 107(12): 4817 - 4824.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
A. Y. Khakoo, S. Pati, S. A. Anderson, W. Reid, M. F. Elshal, I. I. Rovira, A. T. Nguyen, D. Malide, C. A. Combs, G. Hall, et al.
Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma
J. Exp. Med., May 15, 2006; 203(5): 1235 - 1247.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
K. McIntosh, S. Zvonic, S. Garrett, J. B. Mitchell, Z. E. Floyd, L. Hammill, A. Kloster, Y. Di Halvorsen, J. P. Ting, R. W. Storms, et al.
The Immunogenicity of Human Adipose-Derived Cells: Temporal Changes In Vitro
Stem Cells, May 1, 2006; 24(5): 1246 - 1253.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. Stagg, S. Pommey, N. Eliopoulos, and J. Galipeau
Interferon-{gamma}-stimulated marrow stromal cells: a new type of nonhematopoietic antigen-presenting cell
Blood, March 15, 2006; 107(6): 2570 - 2577.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
G. M. Spaggiari, A. Capobianco, S. Becchetti, M. C. Mingari, and L. Moretta
Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation
Blood, February 15, 2006; 107(4): 1484 - 1490.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
J. J. Minguell and A. Erices
Mesenchymal Stem Cells and the Treatment of Cardiac Disease
Experimental Biology and Medicine, January 1, 2006; 231(1): 39 - 49.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Corcione, F. Benvenuto, E. Ferretti, D. Giunti, V. Cappiello, F. Cazzanti, M. Risso, F. Gualandi, G. L. Mancardi, V. Pistoia, et al.
Human mesenchymal stem cells modulate B-cell functions
Blood, January 1, 2006; 107(1): 367 - 372.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Poggi, C. Prevosto, A.-M. Massaro, S. Negrini, S. Urbani, I. Pierri, R. Saccardi, M. Gobbi, and M. R. Zocchi
Interaction between Human NK Cells and Bone Marrow Stromal Cells Induces NK Cell Triggering: Role of NKp30 and NKG2D Receptors
J. Immunol., November 15, 2005; 175(10): 6352 - 6360.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2005 by American Society of Hematology         Online ISSN: 1528-0020